tiprankstipranks
Celldex Therapeutics Inc (DE:TCE2)
FRANKFURT:TCE2
Germany Market

Celldex (TCE2) Technical Analysis

3 Followers

Summary of all the Indicators

Overall Consensus
Neutral
10Bullish
1Neutral
11Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Celldex Therapeutics Inc’s (TCE2) Moving Averages Convergence Divergence (MACD) indicator is -0.42, suggesting Celldex Therapeutics Inc is a Buy.
Celldex Therapeutics Inc’s (TCE2) 20-Day exponential moving average is 33.44, while Celldex Therapeutics Inc’s (TCE2) share price is €33.52, making it a Sell.
Celldex Therapeutics Inc’s (TCE2) 50-Day exponential moving average is 32.89, while Celldex Therapeutics Inc’s (TCE2) share price is €33.52, making it a Sell.

Celldex (TCE2) Pivot Points

Sep 15, 2026, 08:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
31.48
31.72
31.83
32.07
32.18
32.42
32.53
Fibonacci
31.72
31.85
31.93
32.07
32.20
32.28
32.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Celldex (TCE2) Moving Averages

Sep 15, 2026, 08:19 PM
Period
Simple
Exponential
MA5
32.57Sell
32.33Sell
MA10
33.03Sell
32.91Sell
MA20
33.86Sell
33.44Sell
MA50
33.47Sell
32.89Sell
MA100
30.52Buy
31.05Buy
MA200
27.14Buy
28.00Buy
Celldex Therapeutics Inc’s (TCE2) 10-Day exponential moving average is 32.91, while Celldex Therapeutics Inc’s (TCE2) share price is €33.52, making it a Sell.
Celldex Therapeutics Inc’s (TCE2) 100-Day exponential moving average is 31.05, while Celldex Therapeutics Inc’s (TCE2) share price is €33.52, making it a Buy.
Celldex Therapeutics Inc’s (TCE2) stock price is €33.52 and Celldex Therapeutics Inc’s (TCE2) 50-day simple moving average is 33.47, creating a Sell signal.
Celldex Therapeutics Inc’s (TCE2) stock price is €33.52 and Celldex Therapeutics Inc’s (TCE2) 100-day simple moving average is 30.52, creating a Buy signal.
Celldex Therapeutics Inc’s (TCE2) stock price is €33.52 and Celldex Therapeutics Inc’s (TCE2) 200-day simple moving average is 27.14, creating a Buy signal.

Celldex (TCE2) Technical Indicators

Sep 15, 2026, 08:19 PM
Name
Value
Implied Action
RSI (14)
35.02
Neutral
STOCH (9,6)
<0.01
Buy
STOCHRSI (14)
<0.01
Buy
MACD (12,26)
-0.42
Buy
ADX (14)
14.55
Buy
Williams %R
-100.00
Buy
CCI (14)
-187.62
Buy
ATR (14)
0.55
-
Ultimate Oscillator
16.90
Sell
ROC
-11.10
Sell
Celldex Therapeutics Inc’s (TCE2) Relative Strength Index (RSI) is 35.02, creating a Neutral signal.
Celldex Therapeutics Inc’s (TCE2) Trend Strength Indicator (ADX) is 14.55, creating a Buy signal.
Celldex Therapeutics Inc’s (TCE2) Commodity Channel Index (CCI) is -187.62, creating a Buy signal.
Celldex Therapeutics Inc’s (TCE2) Price Rate of Change (ROC) is -11.10, creating a Sell signal.

FAQ

Is TCE2 a Buy, Hold, or Sell?
Based on TCE2’s technical indicators, TCE2 is a Hold.
    What is TCE2’s RSI (14)?
    TCE2’s RSI (14) is 35.02, which suggests TCE2 is a Neutral.
      What is TCE2’s MACD?
      TCE2’s MACD is -0.42, which suggests TCE2 is a Buy.
        What is TCE2’s 5-day moving average?
        TCE2’s 5-day moving average is 32.57, which suggests TCE2 is a Sell.
          What is TCE2’s 20-day moving average?
          TCE2 20-day moving average is 33.86, which suggests TCE2 is a Sell.
            What is TCE2’s 50-day moving average?
            TCE2’s 50-day moving average is 33.47, which suggests TCE2 is a Sell.
              What is TCE2’s 200-day moving average?
              TCE2’s 200-day moving average is 27.14, which suggests TCE2 is a Buy.
                What is TCE2’s Williams % R (14)?
                TCE2’s Williams % R (14) is -100.00, which suggests TCE2 is a Buy.
                  What is TCE2’s CCI (14)?
                  TCE2’s CCI (14) is -187.62, which suggests TCE2 is a Buy.
                    What is the share price of Celldex Therapeutics Inc?